Janssen, Ties L. http://orcid.org/0000-0002-0102-1183
Mosk, Christina A.
van Hoof-de Lepper, Chantal C. H. A.
Wielders, Daphne
Seerden, Tom C. J.
Steyerberg, Ewout W.
van Gammeren, Adriaan J.
de Lange, Dominique C.
van Alphen, René
van der Zee, Martine
de Bruijn, René M.
de Vries, Jolanda
Wijsman, Jan H.
Ho, Gwan H.
Gobardhan, Paul D.
van der Laan, Lijckle
Funding for this research was provided by:
Amphia Fund for Innovation
Vifor Pharma
Article History
Received: 20 June 2018
Accepted: 6 March 2019
First Online: 20 March 2019
Ethics approval and consent to participate
: The Medical Ethical Research Committee of Rotterdam, Maasstad Hospital (TWOR) approved the research protocol, ID number NL55694.101.15, in June 2016. Additionally, the Local Research and Development Committee at the Amphia Hospital approved the protocol (Local ID number 1473.16). Serious adverse events and protocol amendments will be reported to this medical ethical committee. Written informed consent will be obtained from all study participants during the first outpatient clinic visit.
: Not applicable.
: The PhD program of the corresponding author (T.L. Janssen) is funded by an ‘unrestricted grant’ by Amphia Fund for innovation. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.